Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.

Literature DB >> 21307965

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.

A Zeevi¹, R Duquesnoy, G Eiras, H Rabinowich, S Todo, L Makowka, T E Starzl.

Abstract

Entities: Chemical

Year: 1988 PMID： 21307965 PMCID： PMC3034377

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

8 in total

1. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

Authors: S Todo; A J Demetris; Y Ueda; O Imventarza; K Okuda; A Casavilla; S Cemaj; A Ghalab; V Mazzaferro; B S Rhoe
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

2. Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

Authors: T Ochiai; K Nakajima; M Nagata; T Suzuki; T Asano; T Uematsu; T Goto; S Hori; T Kenmochi; T Nakagoori
Journal: Transplant Proc Date: 1987-02 Impact factor: 1.066

3. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors: A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

4. FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes.

Authors: A Sanghvi; V Warty; A Zeevi; W Diven; R Duquesnoy; L Makowka; T E Starzl
Journal: Transplant Proc Date: 1987-10 Impact factor: 1.066

5. Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients.

Authors: A Zeevi; J Fung; T R Zerbe; C Kaufman; B S Rabin; B P Griffith; R L Hardesty; R J Duquesnoy
Journal: Transplantation Date: 1986-05 Impact factor: 4.939

6. IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION.

Authors: S Todo; L Makowka; T Starzl
Journal: Surg Res Commun Date: 1987-01-01

7. IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.

Authors: A Zeevi; R Duquesnoy; G Eiras; S Todo; L Makowka; T Starzl
Journal: Surg Res Commun Date: 1987

8. THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS.

Authors: P Lee; N Murase; S Todo; L Makowka; T Starzl
Journal: Surg Res Commun Date: 1987

8 in total

7 in total

1. Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.

Authors: A Zeevi; G Eiras; F H Bach; J J Fung; S Todo; T Starzl; R J Duquesnoy
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

2. Pharmacokinetics of FK 506: preclinical and clinical studies.

Authors: R Venkataramanan; A Jain; E Cadoff; V Warty; K Iwasaki; K Nagase; A Krajack; O Imventarza; S Todo; J J Fung
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

3. Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506.

Authors: G Eiras; O Imventarza; N Murase; Y Ueda; S Todo; T Starzl; R J Duquesnoy; A Zeevi
Journal: Transplantation Date: 1990-06 Impact factor: 4.939

4. Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.

Authors: A Zeevi; G Eiras; C Kaufman; M Alessiani; A J Demetris; K Abu-Elmagd; A Jain; V Warty; R Venkataramanan; G Burckart
Journal: Transplant Proc Date: 1991-02 Impact factor: 1.066